FindTrial
Sign In

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

Comparative Clinicomycologic and Dermoscopic Study Between Daily and Pulse Therapy of Oral Itraconazole in Tinea Capitis in Children

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07184203
Enrollment
120
Registered
2025-09-19
Start date
2025-03-09
Completion date
2025-12-31
Last updated
2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinea Capitis

Brief summary

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Interventions

DRUGItraconazole (ITZ)

therapy for tinea capitis orally

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

• Tinea capitis patients with ages ranging from 5 to 18 year

Exclusion criteria

* Patients with contraindications to itraconazole * Patients with associated scalp disease. * Patients weighing less than 20 Kg.

Design outcomes

Primary

MeasureTime frameDescription
improvement of tinea capitis3 monthscure of tinea capitis

Countries

Egypt

Contacts

Primary ContactMarina K Aioub
marinaaioub10@gmail.com00201223805043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026